Using continuous glucose monitoring to help older adults with diabetes
Official title: Building a Real-World Evidence Base for Continuous Glucose Monitoring in Older Adults with Diabetes
Funded at Univ of North Carolina Chapel Hill · NIH-11019774 · Data updated 2026-11-12
This study is looking at how using continuous glucose monitors can help older adults with diabetes manage their condition better and improve their overall well-being.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | February 1, 2024 |
| Project end | January 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $127,380 |
| NIH project number | 5K01AG084971-02 |
| Project ID | NIH-11019774 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults aged 65 and above who have diabetes and may benefit from advanced glucose monitoring technologies.
✕Less likely to help
Patients under the age of 65 or those without diabetes may not receive any benefit from this research.
What this research studies
This research investigates how continuous glucose monitoring (CGM) can improve diabetes management for older adults, particularly those aged 65 and above. By analyzing healthcare data, the study aims to understand the real-world effectiveness of CGM in enhancing clinical outcomes and quality of life for this population. The research will also explore the economic implications of adopting CGM technology, ensuring that it is accessible and beneficial for older adults with diabetes and related health issues.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and better health outcomes for older adults through the effective use of continuous glucose monitoring.
How similar studies have gone: Previous research has shown that technology-based approaches like CGM can significantly improve diabetes management, indicating a promising avenue for this study.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Kahkoska, Anna Rachel — Univ of North Carolina Chapel Hill
- Study coordinator: Kahkoska, Anna Rachel
Related research
Other NIH-funded projects on the same topics.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Retinal signals in early diabetes and how they affect vision
This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Bringing WHO HEARTS-D diabetes care into Bangladesh cities
A program to help urban clinics in Bangladesh adopt WHO HEARTS-D guidelines to improve detection, treatment, and control of type 2 diabetes.
-
AI-powered fundus imaging to screen for type 2 diabetes
A mobile AI tool uses eye images to help screen adults for type 2 diabetes in clinics or communities.
-
AI-powered eye imaging to screen for type 2 diabetes with a mobile phone
A plan to use AI on smartphone retinal images to help spot type 2 diabetes early, especially in people who may not have easy access to care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.